Healthcare Services

Search documents
IQVIA (IQV) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ZACKS· 2025-05-01 14:21
Wall Street analysts expect IQVIA Holdings (IQV) to post quarterly earnings of $2.63 per share in its upcoming report, which indicates a year-over-year increase of 3.5%. Revenues are expected to be $3.77 billion, up 0.9% from the year-ago quarter.Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timefr ...
QuadMed Named 2025 Best in KLAS for Employer-Sponsored Healthcare Services
Prnewswire· 2025-05-01 13:00
Health Care Experience Company Unveils Bold New Brand Reflecting Its EvolutionSUSSEX, Wis., May 1, 2025 /PRNewswire/ -- QuadMed, LLC, a subsidiary of Quad, Inc. (NYSE: QUAD), has been named 2025 Best in KLAS in the Employer-Sponsored Health Care Services category. This recognition, based on direct feedback from clients, validates QuadMed's commitment to delivering a better health care experience by improving outcomes, lowering costs, and simplifying care for clients and members. QuadMed's Dr. Kathryn Qu ...
Sotera Health(SHC) - 2025 Q1 - Earnings Call Transcript
2025-05-01 13:00
Sotera Health Company (SHC) Q1 2025 Earnings Call May 01, 2025 09:00 AM ET Company Participants Jason Peterson - VP & TreasurerMichael Petras - Chairman & CEOJonathan Lyons - Senior VP & CFODavid Windley - Managing Director Conference Call Participants Patrick Donnelly - Managing Director, Equity Research AnalystBrett Fishbin - Vice President & Equity Research AnalystMathew Sykes - AnalystLuke Sergott - AnalystJason Bednar - Senior Research AnalystMike Polark - Senior Equity Research Analyst Operator Please ...
Boost Your Portfolio With These 5 Low Price-to-Book Stocks
ZACKS· 2025-04-30 14:10
Valuation Metrics - The price-to-earnings (P/E) ratio is a common valuation metric, but for companies with losses or minimal profits, the price-to-sales (P/S) ratio is more effective in identifying undervalued stocks [1] - The price-to-book (P/B) ratio is another useful tool for identifying low-priced stocks with high growth potential, calculated by dividing the stock's current price by its book value per share [2][6] Book Value - Book value represents the total value remaining for shareholders if a company were to liquidate its assets after settling all liabilities, calculated by subtracting total liabilities from total assets [4][5] - A P/B ratio of less than one indicates that a stock is trading below its book value, suggesting it may be undervalued, while a ratio above one may indicate overvaluation [6][7] Stock Examples - Centene Corporation (CNC) is a diversified healthcare company with a projected 3-5 year EPS growth rate of 11.5%, currently holding a Zacks Rank of 2 and a Value Score of A [16][17] - Pediatrix Medical Group (MD) provides specialized physician services with a projected EPS growth rate of 9.5% and also holds a Zacks Rank of 2 and a Value Score of A [18][19] - Pfizer (PFE), a major pharmaceutical company, has a projected EPS growth rate of 13.8% and maintains a Zacks Rank of 2 and a Value Score of A [19] - StoneCo (STNE) offers financial technology solutions with a projected EPS growth rate of 26.3%, holding a Zacks Rank of 1 and a Value Score of B [20] - Banco Santander (SAN), the largest bank in Spain, has a projected EPS growth rate of 9.6% and a Zacks Rank of 2 with a Value Score of A [21][22] Screening Parameters - Stocks with a P/B ratio less than the industry median indicate potential for price appreciation [12] - A P/S ratio lower than the industry average makes a stock more attractive [12] - A P/E ratio (F1) below the industry median is considered favorable [13] - A PEG ratio of less than 1 suggests that a stock is undervalued relative to its growth prospects [14] - Stocks should have a minimum trading price of $5 and an average 20-day volume of at least 100,000 for better liquidity [15]
Tenet Health(THC) - 2025 Q1 - Earnings Call Transcript
2025-04-29 19:01
Tenet Healthcare (THC) Q1 2025 Earnings Call April 29, 2025 03:01 PM ET Speaker0 Good morning, and welcome to Tenant Healthcare's First Quarter twenty twenty five Earnings Conference Call. After the speakers' remarks, there will be a question and answer session for industry analysts. I'll now turn the call over to your host, Mr. Will McDowell, Vice President, Investor Relations. Mr. McDowell, you may begin. Speaker1 Good morning, everyone, and thank you for joining today's call. I am Will McDowell, Vice Pre ...
Tenet (THC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-04-29 15:30
Tenet Healthcare (THC) reported $5.22 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 2.7%. EPS of $4.36 for the same period compares to $3.22 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $5.14 billion, representing a surprise of +1.64%. The company delivered an EPS surprise of +40.19%, with the consensus EPS estimate being $3.11.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ...
FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT
Globenewswire· 2025-04-29 14:05
Core Viewpoint - FOXO Technologies Inc. has completed a 1 for 10 reverse stock split of its outstanding common stock, effective April 28, 2025, with trading resuming on a post-split basis on April 29, 2025 [1][2][3]. Group 1: Reverse Stock Split Details - The reverse stock split consolidates every 10 shares of common stock into one share, maintaining the nominal par value per share at $0.0001 [2]. - The number of shares will decrease from approximately 38.7 million to approximately 3.87 million post-split [3]. - All outstanding preferred shares, stock options, warrants, and equity incentive plans will be adjusted accordingly, with the number of shares divided by 10 and the exercise or conversion price multiplied by 10 [4]. Group 2: Administrative Aspects - Continental Stock Transfer & Trust Company has been retained as the exchange agent for the reverse stock split, providing instructions for stockholders of record [5]. - Stockholders with shares held through brokers will have their positions automatically adjusted without needing to take action [5]. - The reverse split was approved by the Company's directors on April 17, 2025, following a majority shareholder resolution on November 29, 2024 [6]. Group 3: Company Overview - FOXO Technologies Inc. operates three subsidiaries: Rennova Community Health, which owns Scott County Community Hospital, Myrtle Recovery Centers, a behavioral health facility, and Foxo Labs, a biotechnology company focused on health and lifespan improvement [7][8].
Tenet Health(THC) - 2025 Q1 - Earnings Call Transcript
2025-04-29 14:00
Tenet Healthcare (THC) Q1 2025 Earnings Call April 29, 2025 10:00 AM ET Company Participants William McDowell - Vice President - Investor RelationsSaum Sutaria - Chairman of The Board & CEOSun Park - Executive VP & CFOCraig Hettenbach - Executive DirectorMeghan Holtz - VP, Healthcare Services Equity ResearchBen Hendrix - Vice PresidentWhit Mayo - Senior Managing DirectorBenjamin Rossi - Equity Research AssociateA.J. Rice - Managing DirectorAndrew Mok - DirectorJoshua Raskin - Partner - Managed Care & Provid ...
Acentra Health Awarded $27.5 Million Contract from California Medicaid to Continue Providing Preadmission Screening and Resident Review (PASRR) Services
GlobeNewswire News Room· 2025-04-29 13:34
Core Insights - Acentra Health has been awarded a two-year contract worth $27.5 million by the California Department of Health Care Services to provide Level I screenings and Level II evaluations for serious mental illness as part of the PASRR program [1][2] - The company has a long-standing partnership with California Medicaid, having delivered PASRR services since 2015, and is recognized for its efficiency and effectiveness in this area [2][4] - California's PASRR program is the largest in the nation, with Acentra Health conducting approximately 233,000 initial screenings and 18,000 Level II evaluations annually, achieving turnaround times averaging fewer than two calendar days [4][5] Company Overview - Acentra Health specializes in technology and health solutions aimed at improving outcomes for government and commercial healthcare clients [1][7] - The company has over 30 years of experience in evaluating medical necessity for Medicaid beneficiaries and provides a range of PASRR services, including screenings, evaluations, and IT systems [6][7] - Acentra Health has expanded its PASRR portfolio to eight states, recently adding Kansas and Washington, indicating growth and increased market presence [5]
Appian Celebrates 2025 Innovation Award Winners
Prnewswire· 2025-04-29 13:30
Customers Delivered Value with Process Orchestration and AI Capabilities on the Appian PlatformDENVER, April 29, 2025 /PRNewswire/ -- Appian (Nasdaq: APPN) today announced the 2025 Appian Innovation Awards winners at Appian World, its annual global conference. The Innovation Awards celebrate customers for creating transformative applications that drive impact and value on the Appian Platform. By embedding AI agents and generative AI in process orchestration, these winners have demonstrated that process, com ...